One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
India at 75 years: progress, challenges, and opportunities
doi : 10.1016/S0140-6736(22)01525-2
Volume 400, Issue 10351, 13–19 August 2022, Page 469
An energy booster for thalassaemic red blood cells
AntonisKattamisa
Biologic therapies for asthma in underserved populations
Rachel SKellyaScott TWeissa
Participation in phase 1 trials for patients with cancer
AntoineItalianoabc
A historic opportunity for universal health coverage in India
VikramPatelabShubhangiBhadadacKiranMazumdar-ShawdArnabMukherjieTarunKhannafGagandeepKangg
Use the remaining carbon budget wisely for health equity and climate justice
AndyHainesa
Turkish doctors emigrate amid low pay and rising violence
KayaGenc
Poornima Prabhakaran: advocate for health in a changing climate
AarathiPrasad
“You have not remained the same, nor have I�
ZainabGolwalaaAshwinPandeybRobindra BasuRoybc
Screening policies for cytomegalovirus in pregnancy in the era of antivirals
Sophie LouiseRobertsaGiles SKendalldSarahEdwardsfPranavPandyabeDonaldPeeblesbeEleniNastouliac
Iran's burden of disease and burden of data collection
Christopher GerardMaheraGiovanniFerreiraa
Iran's burden of disease and burden of data collection
Seyed MohammadrezaHashemianaJamesMillerb
Iran's burden of disease and burden of data collection – Authors' reply
Sadaf GSepanlouadSahar SaeediMoghaddambFarshadFarzadfarbRezaMalekzadehadBagherLarijanicNicole DavisWeavereMohsenNaghavief
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot
Eric MSnyderaRyanSprisslerabThomas POlsonac
Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot – Authors' reply
FelixMahfoudaDavid EKandzaribMichael AWebercMartinFahydMichaelBöhma
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study
Kevin H MKuoMDaProfD MarkLaytonMBBSbProfAshutoshLalMDcHannyAl-SamkariMDdJoyBhatiaMDePenelope AKosinskiMSeBoTongPhDeMeganLynchMSNeKatrinUhligMDeElliott PVichinskyMDc
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial
ProfDaniel JJacksonMDrtProfLeonard BBacharierMDaPeter JGergenMDbLisaGagalisBSNbAgustinCalatroniMScStephanieWellfordBAcMichelle AGillMDdJeffreyStokesMDdProfAndrew HLiuMDfProfRebecca SGruchallaMDhRobyn TCohenMDiMelanieMakhijaMDjProfGurjit KKhurana HersheyMDlProfGeorge TO'ConnorMDiProfJacqueline APongracicMDjMichael GSherenianMDklKatherineRivera-SpoljaricMDdeProfEdward MZorattiMDm…Matthew CAltmanMDqu
Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials
DaiChiharaMDacRuitaoLinPhDbProfChristopher RFlowersMDaShanda RFinniganMPHdLisa MCordesPharmDeYokoFukudaMDdErich PHuangPhDfLarry VRubinsteinPhDfLoretta JNastoupilMDaS PercyIvyMDdJames HDoroshowMDdNaokoTakebeMDd
No clubbing in the fingers, only in the toes: patent ductus arteriosus and reversed shunting
VijayanGanesanMDaViswananthaKartikMDbAjayAlexMDc
The multispeciality approach to the management of localised kidney cancer
ProfGrant DStewartPhDabdTobiasKlatteMDaeLauraCosmaiMDfProfAxelBexPhDghiBenjamin WLambFRCSdjProfHolgerMochMDkProfEvisSalaMDbcShankarSivaPhDlCamilloPortaMDmn†ProfMaurizioGallieniMDfoâ€
Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA
ProfMichelle MMelloPhDabeProfDouglas JOpelMDghRegina MBenjaminMDiTimothyCallaghanPhDjReneeDiRestaBSfJad AElharakeMPHkProfLisa CFlowersMDpProfAlison PGalvaniPhDlProfDaniel ASalmonPhDqJason LSchwartzPhDmProfNoel TBrewerPhDsAlison MButtenheimPhDtProfRichard MCarpianoPhDuChelseaClintonDPhilvwxProfPeter JHotezMDyzaaabRekhaLakshmananMHAzacProfYvonne AMaldonadoMDcdProfSaad BOmerPhDkno…ProfArthurCaplanPhDad
